college of agriculture and life sciences has found an inexpensive way to produce hydrogen from plants.
supposed to be a game changer for the alternate energy markets.
may be a commercial process in 3 years.
CEO had to sell some shares as his salary is only $1.2 mil/yr. He really does have a poor record of running the company. However, it is our problem as we chose poorly! Drones are a competitive field. Large companies have a lot more resources. I think they are taking the business from AVAV. (AVAV would never admit that).
$400 million valuation buys you 1.1 billion oz of measured and indicated reserves of silver. It may be even higher since reserves at Pittarilla have been upgraded recently. In 2012 SSRI management said the valuation at $15.50 was compelling. Must be even more compelling now. I am new to silver stocks. Trying to learn fast so as to take advantage of the sell-off. Am I right about about the valuation? This company doesn't produce much as of now. Is it relatively safe to invest based on reserve estimates (measured and indicated)?
Merrill Lynch has a price objective of $11. They write the following:
"PBCT reported Q4 GAAP EPS of $0.18, below our $0.19 estimate and consensus
as stronger fee income and asset growth were not enough to offset continued rate
pressure. Positively, provisions were lower QoQ and credit trends remain benign.
Opex discipline was somewhat helpful. PBCT also continued its share
repurchases, buying back another 4.7M shares for $56M, making it a total of
18.2M shares for the year. That said, rate pressure continued to impact asset
yields, with key segments falling further. PBCT also guided for more severe
margin compression ahead, with NIM in the 3.30-3.40% range for 2013, down
from 3.63% in Q4. Overall, we see little relief in the near-to-medium term as
PBCT continues to be negatively impacted by the challenging rate environment.
"Capital levels remain healthy; dividend stable
Capital levels in Q4 were healthy, with a TCE ratio of 10.2%, down from 11.5% in
Q3. Tangible book value at Q4 was $8.71, down from $8.77 last quarter. During
the quarter PBCT bought back 4.7M shares for ~$56M. For 2012, PBCT bought
back ~18.2M shares for ~$220M. PBCT has 33.4M shares available for
repurchase under Nov 2012’s new share repurchase authorization. Finally, PBCT
kept its $0.16 per share quarterly dividend, with a payout ratio of ~88% in Q4 vs.
87% in Q3. We see PBCT’s dividend as relatively stable, given its healthy capital
hard to find any stock whose price is now lower than in March 2009. PBCT is one of a few. Sentiment was horrible back then. I suspect things are not good for this company. I cannot find any good comments from the brokers. Seems like no one is interested. Maybe there are too many banks in the Northeast and competition is too much. comments about management is disheartening. Maybe they are incompetent.